Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.44%89.041.3%$807.52m
AMGNAmgen Inc.
1.02%187.391.2%$635.40m
GILDGilead Sciences, Inc.
0.35%65.780.9%$483.98m
BIIBBiogen Inc.
1.16%324.911.3%$432.42m
ILMNIllumina, Inc.
1.36%300.933.5%$315.60m
REGNRegeneron Pharmaceuticals, Inc.
1.02%422.902.6%$293.15m
VRTXVertex Pharmaceuticals Incorporated
1.08%185.031.9%$256.31m
ALXNAlexion Pharmaceuticals, Inc.
1.28%129.182.0%$222.49m
SRPTSarepta Therapeutics, Inc.
2.57%140.0515.4%$156.25m
AAgilent Technologies, Inc.
0.45%78.241.6%$151.48m
EXASExact Sciences Corporation
9.28%91.0125.3%$144.56m
INCYIncyte Corporation
1.37%84.472.5%$113.47m
ARRYArray BioPharma Inc.
4.12%23.658.2%$112.48m
EXELExelixis, Inc.
0.52%21.336.4%$82.49m
NBIXNeurocrine Biosciences, Inc.
2.68%79.385.1%$79.29m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.